Results
76,375 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Sylebra Capital LlcDirector, 10% Owner |  PCTPureCycle Technologies, Inc.Disposition to issuer | D | — |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Sylebra Capital LlcDirector, 10% Owner | PCTPureCycle Technologies, Inc. Disposition to issuer | D | — |
| Jun 16, 2026 traded Jun 15, 2026 |
| 4 | Kuykendall AnneSVP and Chief Legal Officer |  PENGPenguin Solutions, Inc.Open-market sale · 10b5-1 plan | SELL | $135K 2,104 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 4 | Graham-Cumming JohnDirector |  NETCloudflare, Inc.Option exercise · 10b5-1 plan | M | — 2,520 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 4 | Kuykendall AnneSVP and Chief Legal Officer | PENGPenguin Solutions, Inc. Open-market sale · 10b5-1 plan | SELL | $103K 1,596 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 3 | Chairman DavidSVP, R&D |  VLNValens Semiconductor Ltd.Open-market sale · 10b5-1 plan | SELL | $9,730 4,000 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 2 | Freeman ChrisChief Commercial Officer |  GHGuardant Health, Inc.Option exercise | M | — 1,402 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 2 | Freeman ChrisChief Commercial Officer | GHGuardant Health, Inc. Option exercise | M | — 1,402 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 1 | Ahearn Matthew FraserDirector, Chief Operating Officer |  SISHOULDER INNOVATIONS, INC.Open-market sale · 10b5-1 plan | SELL | $48K 2,500 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 1 | Ahearn Matthew FraserDirector, Chief Operating Officer | SISHOULDER INNOVATIONS, INC. Open-market sale · 10b5-1 plan | SELL | $30K 1,644 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 1 | Kuykendall AnneSVP and Chief Legal Officer | PENGPenguin Solutions, Inc. Open-market sale · 10b5-1 plan | SELL | $6,563 100 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 1 | Kuykendall AnneSVP and Chief Legal Officer | PENGPenguin Solutions, Inc. Open-market sale · 10b5-1 plan | SELL | $13K 200 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 1 | Fiedler-Kelly JillPresident, Services Solutions |  SLPSimulations Plus, Inc.Open-market sale · 10b5-1 plan | SELL | $17K 1,050 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Fiedler-Kelly JillPresident, Services Solutions | SLPSimulations Plus, Inc. Option exercise · 10b5-1 plan | M | — 1,050 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Tan Anthony Ping YeowDirector, Chief Executive Officer |  GRABGrab Holdings LtdDerivative conversion · 10b5-1 plan | C | — 800.0K sh | Jun 16, 2026 traded Jun 12, 2026 |
| 0 | Chairman DavidSVP, R&D | VLNValens Semiconductor Ltd. Option exercise · 10b5-1 plan | M | $3,440 4,000 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Chairman DavidSVP, R&D | VLNValens Semiconductor Ltd. Option exercise · 10b5-1 plan | M | — 4,000 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Fiedler-Kelly JillPresident, Services Solutions | SLPSimulations Plus, Inc. Option exercise · 10b5-1 plan | M | $11K 1,050 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Alvarez Divo Carlos EduardoDirector |  EXFYExpensify, Inc.Open-market sale · 10b5-1 plan | SELL | $14K 10.7K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Ellenbogen MichaelDirector |  EVLVEvolv Technologies Holdings, Inc.Option exercise · 10b5-1 plan | M | $19K 80.7K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Graham-Cumming JohnDirector | NETCloudflare, Inc. Option exercise · 10b5-1 plan | M | $113K 2,520 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Tariq MusaDirector | GHGuardant Health, Inc. Option exercise · 10b5-1 plan | M | — 250 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Weingarten TomerDirector, President, CEO |  SSentinelOne, Inc.Derivative conversion · 10b5-1 plan | C | — 57.9K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary |  VGVenture Global, Inc.Option exercise · 10b5-1 plan | M | — 555.6K sh | Jun 16, 2026 traded Jun 16, 2026 |
| 0 | Ellenbogen MichaelDirector | EVLVEvolv Technologies Holdings, Inc. Option exercise · 10b5-1 plan | M | — 80.7K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Rozenberg Haine YaelVP Finance | VLNValens Semiconductor Ltd. Option exercise · 10b5-1 plan | M | $1,250 1,453 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Weingarten TomerDirector, President, CEO | SSentinelOne, Inc. Derivative conversion · 10b5-1 plan | C | — 57.9K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | $439K 555.6K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Rozenberg Haine YaelVP Finance | VLNValens Semiconductor Ltd. Option exercise · 10b5-1 plan | M | — 1,453 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Tariq MusaDirector | GHGuardant Health, Inc. Option exercise · 10b5-1 plan | M | — 250 sh | Jun 16, 2026 traded Jun 15, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | $439K 555.6K sh | Jun 16, 2026 traded Jun 16, 2026 |
| 0 | Larson Keith DGeneral Counsel and Secretary | VGVenture Global, Inc. Option exercise · 10b5-1 plan | M | — 555.6K sh | Jun 16, 2026 traded Jun 15, 2026 |
| 54 | Da Cunha Gustavo WerneckCEO and Board Member |  GGBGERDAU S.A.Open-market purchase | BUY | $782K 165.2K sh | Jun 15, 2026 traded Jun 12, 2026 |
| 52 | Clark Benjamin M.EVP - Global Supply Chain |  ECLECOLAB INC.Open-market purchase | BUY | $264K 1,000 sh | Jun 15, 2026 traded Jun 11, 2026 |
| 51 | Rosenberg AaronChief Financial Officer |  ONCBeOne Medicines Ltd.Open-market sale | SELL | $163K 631 sh | Jun 15, 2026 traded Jun 11, 2026 |
| 50 | Haas JasonDirector |  LGNDLIGAND PHARMACEUTICALS INCOpen-market sale | SELL | $765K 3,000 sh | Jun 15, 2026 traded Jun 12, 2026 |
| 50 | Haas JasonDirector | LGNDLIGAND PHARMACEUTICALS INC Open-market sale | SELL | $886K 3,461 sh | Jun 15, 2026 traded Jun 12, 2026 |
| 50 | Kuczinski Anthony JDirector |  RYANRYAN SPECIALTY HOLDINGS, INC.Open-market purchase | BUY | $87K 2,500 sh | Jun 15, 2026 traded Jun 11, 2026 |
| 47 | Davis Todd CDirector |  PTHSPelthos Therapeutics Inc.Open-market purchase | BUY | $986K 35.4K sh | Jun 15, 2026 traded Jun 11, 2026 |
| 47 | Wang LaiPresident, Global Head of R&D | ONCBeOne Medicines Ltd. Open-market sale | SELL | $197K 756 sh | Jun 15, 2026 traded Jun 11, 2026 |
| 44 | Lee Chan HenrySVP, General Counsel | ONCBeOne Medicines Ltd. Open-market sale | SELL | $110K 428 sh | Jun 15, 2026 traded Jun 11, 2026 |